Gender, Race, and Variation in the Evaluation of Microscopic Hematuria Among Medicare Beneficiaries

Journal of General Internal Medicine

Volumn 30, Issue 4, 2015, Pages 440-447

  Bassett, Jeffrey C ^a,b   Alvarez, Jo Ann ^c   Koyama, Tatsuki ^c   Resnick, Matthew ^a,b   You, Chaochen ^a   Ni, Shenghua ^a   Penson, David F ^a,b   Barocas, Daniel A ^a,b  

^a VANDERBILT UNIVERSITY MEDICAL CENTER   (United States)

^b VANDERBILT UNIVERSITY   (United States)

^c VANDERBILT UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

diagnostic evaluation; health care disparity; hematuria; urinary bladder neoplasms; variability in practice

Indexed keywords

AFRICAN AMERICAN; AGED; ANCESTRY GROUP; CAUCASIAN; COHORT ANALYSIS; ETHNOLOGY; FEMALE; HEMATURIA; HUMAN; INSURANCE; MALE; MEDICARE; RETROSPECTIVE STUDY; SEX DIFFERENCE; STANDARDS; UNITED STATES; VERY ELDERLY;

AFRICAN AMERICANS; AGED; AGED, 80 AND OVER; COHORT STUDIES; CONTINENTAL POPULATION GROUPS; EUROPEAN CONTINENTAL ANCESTRY GROUP; FEMALE; HEMATURIA; HUMANS; INSURANCE BENEFITS; MALE; MEDICARE; RETROSPECTIVE STUDIES; SEX FACTORS; UNITED STATES;

EID: 84939988727     PISSN: 08848734     EISSN: 15251497     Source Type: Journal    
DOI: 10.1007/s11606-014-3116-2     Document Type: Article

References (43)

1. Howlander N, Noone AM, Krapcho M, et al.SEER Cancer Statistics Review, 1975–2010, National Cancer Institute. Bethesda, MD; Available at: http://seer.cancer.gov/csr/1975_2010/. Retrieved October 30, 2014.
2. Mohr DN, Offord KP, Owen RA, Melton LJ 3rd. Asymptomatic microhematuria and urologic disease. A population-based study. JAMA. 1986;256(2):224–9.
3. Mariani AJ, Mariani MC, Macchioni C, Stams UK, Hariharan A, Moriera A. The significance of adult hematuria: 1,000 hematuria evaluations including a risk-benefit and cost-effectiveness analysis. J Urol. 1989;141(2):350–5.
4. Messing EM, Young TB, Hunt VB, Wehbie JM, Rust P. Urinary tract cancers found by homescreening with hematuria dipsticks in healthy men over 50 years of age. Cancer. 1989;64(11):2361–7.
5. Sultana SR, Goodman CM, Byrne DJ, Baxby K. Microscopic haematuria: urological investigation using a standard protocol. Br J Urol. 1996;78(5):691–696. discussion 697–8.
6. Khadra MH, Pickard RS, Charlton M, Powell PH, Neal DE. A prospective analysis of 1,930 patients with hematuria to evaluate current diagnostic practice. J Urol. 2000;163(2):524–7.
7. Grossfeld GD, Litwin MS, Wolf JS Jr, et al. Evaluation of asymptomatic microscopic hematuria in adults: the American Urological Association best practice policy-part II: patient evaluation, cytology, voided markers, imaging, cystoscopy, nephrology evaluation, and follow-up. Urology. 2001;57(4):604–10.
8. Davis R, Jones JS, Barocas DA, et al. Diagnosis, evaluation and follow-up of asymptomatic microhematuria (AMH) in adults: AUA guideline. J Urol. 2012;188(6 Suppl):2473–81.
9. Buteau A, Seideman CA, Svatek RS, et al. What is evaluation of hematuria by primary care physicians? Use of electronic medical records to assess practice patterns with intermediate follow-up. Urol Oncol. 2014;32(2):128–34.
10. Friedlander DF, Resnick MJ, You C, et al. Variation in the Intensity of Hematuria Evaluation: A Target for Primary Care Quality Improvement. Am J Med. Jan 28 2014.
11. Elias K, Svatek RS, Gupta S, Ho R, Lotan Y. High-risk patients with hematuria are not evaluated according to guideline recommendations. Cancer. 2010;116(12):2954–9.
12. Hollenbeck BK, Dunn RL, Ye Z, et al. Delays in diagnosis and bladder cancer mortality. Cancer. 2010;116(22):5235–42.
13. Cohn JA, Vekhter B, Lyttle C, Steinberg GD, Large MC. Sex disparities in diagnosis of bladder cancer after initial presentation with hematuria: A nationwide claims-based investigation. Cancer. 2014;120(4):555–61.
14. Klabunde CN, Potosky AL, Legler JM, Warren JL. Development of a comorbidity index using physician claims data. J Clin Epidemiol. 2000;53(12):1258–67.
15. Krieger N. Overcoming the absence of socioeconomic data in medical records: validation and application of a census-based methodology. Am J Public Health. 1992;82(5):703–10.
16. Krieger N, Williams DR, Moss NE. Measuring social class in US public health research: concepts, methodologies, and guidelines. Annu Rev Public Health. 1997;18:341–78.
17. Area Resurce File (ARF); National county-level Health Resource Information Database. 2012; Available at: http://ahrf.hrsa.gov/. Retrieved October 30, 2014.
18. Prout GR Jr, Wesley MN, Greenberg RS, et al. Bladder cancer: race differences in extent of disease at diagnosis. Cancer. 2000;89(6):1349–58.
19. Cardenas-Turanzas M, Cooksley C, Pettaway CA, Sabichi A, Grossman HB, Elting L. Comparative outcomes of bladder cancer. Obstet Gynecol. 2006;108(1):169–75.
20. Lee CT, Dunn RL, Williams C, Underwood W 3rd. Racial disparity in bladder cancer: trends in tumor presentation at diagnosis. J Urol. Sep. 2006;176(3):927–933. discussion 933–24.
21. Mallin K, David KA, Carroll PR, Milowsky MI, Nanus DM. Transitional cell carcinoma of the bladder: racial and gender disparities in survival (1993 to 2002), stage and grade (1993 to 2007). J Urol. May. 2011;185(5):1631–6.
22. Mungan NA, Aben KK, Schoenberg MP, et al. Gender differences in stage-adjusted bladder cancer survival. Urology. 2000;55(6):876–80.
23. Scosyrev E, Noyes K, Feng C, Messing E. Sex and racial differences in bladder cancer presentation and mortality in the US. Cancer. 2009;115(1):68–74.
24. Institute of Medicine. Coverage Matters: Insurance and Health Care. Washington: National Academies Press; 2001.
25. Institute of Medicine. Unequal Treatment: Confronting Racial and Ethnic Disparities in Health Care. Washington: National Academies Press; 2002.
26. Prout GR Jr, Wesley MN, McCarron PG, et al. Survival experience of black patients and white patients with bladder carcinoma. Cancer. 2004;100(3):621–30.
27. Bach PB, Schrag D, Brawley OW, Galaznik A, Yakren S, Begg CB. Survival of blacks and whites after a cancer diagnosis. JAMA. 2002;287(16):2106–13.
28. Taub DA, Hollenbeck BK, Cooper KL, et al. Racial disparities in resource utilization for cystectomy. Urology. 2006;67(2):288–93.
29. Konety BR, Allareddy V, Carroll PR. Factors affecting outcomes after radical cystectomy in African Americans. Cancer. 2007;109(3):542–8.
30. Barocas DA, Alvarez J, Koyama T, et al. Racial variation in the quality of surgical care for bladder cancer. Cancer. 2014;120(7):1018–25.
31. Konety BR, Joslyn SA. Factors influencing aggressive therapy for bladder cancer: an analysis of data from the SEER program. J Urol. 2003;170(5):1765–71.
32. Fedeli U, Fedewa SA, Ward EM. Treatment of muscle invasive bladder cancer: evidence from the National Cancer Database, 2003 to 2007. J Urol. 2011;185(1):72–8.
33. Franks P, Zwanziger J, Mooney C, Sorbero M. Variations in primary care physician referral rates. Health Serv Res. 1999;34(1 Pt 2):323–9.
34. Franks P, Williams GC, Zwanziger J, Mooney C, Sorbero M. Why do physicians vary so widely in their referral rates? J Gen Intern Med. 2000;15(3):163–8.
35. Siegel R, Naishadham D, Jemal A. Cancer statistics, 2012. CA Cancer J Clin. 2012;62(1):10–29.
36. Johnson EK, Daignault S, Zhang Y, Lee CT. Patterns of hematuria referral to urologists: does a gender disparity exist? Urology. 2008;72(3):498–502. discussion 502–493
37. Lyratzopoulos G, Abel GA, McPhail S, Neal RD, Rubin GP. Gender inequalities in the promptness of diagnosis of bladder and renal cancer after symptomatic presentation: evidence from secondary analysis of an English primary care audit survey. BMJ Open. 2013;3(6).
38. Miller DC, Murtagh DS, Suh RS, et al. Regional collaboration to improve radiographic staging practices among men with early stage prostate cancer. J Urol. 2011;186(3):844–9.
39. Burks FN, Liu AB, Suh RS, et al. Understanding the use of immediate intravesical chemotherapy for patients with bladder cancer. J Urol. 2012;188(6):2108–13.
40. Barocas DA, Liu A, Burks FN, et al. Practice based collaboration to improve the use of immediate intravesical therapy after resection of nonmuscle invasive bladder cancer. J Urol. 2013;190(6):2011–16.
41. Loo RK, Lieberman SF, Slezak JM, et al. Stratifying risk of urinary tract malignant tumors in patients with asymptomatic microscopic hematuria. Mayo Clin Proc. 2013;88(2):129–38.
42. Lillie-Blanton M, Brodie M, Rowland D, Altman D, McIntosh M. Race, ethnicity, and the health care system: public perceptions and experiences. Med Care Res Rev. 2000;57(Suppl 1):218–35.
43. Burgess DJ, Fu SS, van Ryn M. Why do providers contribute to disparities and what can be done about it? J Gen Intern Med. 2004;19(11):1154–9.